On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Teva Pharmaceutical Industries Limited's own share of each project, not the project's full budget.
- Horizon 2020€260k · 11 projects
- Horizon Europe€0 · 1 project
Projects
12 EU-funded projects, newest first. Each links to the official record.
- BRIDGEPartner
Breakthrough Regulatory Innovation and Development throuGh sandbox Environments
Horizon Europe · 2025–2028 · Project on CORDIS ↗
- EPNDPartner
European platform for neurodegenerative disorders
Horizon 2020 · 2021–2026 · Project on CORDIS ↗
- RealHOPEPartner
Real World Handling of Protein Drugs - Exploration, Evaluation and Education
Horizon 2020 · 2021–2025 · Project on CORDIS ↗
- EU-PEARLPartner
EU Patient- cEntric clinicAl tRial pLatform
Horizon 2020 · 2019–2023 · Project on CORDIS ↗
- Trials@HomePartner
Trials@Home: Center of Excellence – Remote Decentralised Clinical Trials
Horizon 2020 · 2019–2025 · Project on CORDIS ↗
- MOBILISE-DPartner
Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement
Horizon 2020 · 2019–2024 · Project on CORDIS ↗
- ConcePTIONPartner
Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised evidence generation
Horizon 2020 · 2019–2024 · Project on CORDIS ↗
- PD-MitoQUANTPartner
PD-MitoQUANT – A quantitative approach towards the characterisation of mitochondrial dysfunction in Parkinson's disease
Horizon 2020 · 2019–2022 · Project on CORDIS ↗
- AIMS-2-TRIALSPartner
Autism Innovative Medicine Studies – 2 – Trials
Horizon 2020 · 2018–2026 · Project on CORDIS ↗
- IMI-PainCarePartner
Improving the care of patients suffering from acute or chronic pain
Horizon 2020 · 2018–2023 · Project on CORDIS ↗
- THERACATPartner
Bio-orthogonal catalysis for cancer therapy
Horizon 2020 · 2018–2022 · Project on CORDIS ↗
€260ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Novartis Pharma AGSwitzerland · 9 shared projects
- Janssen Pharmaceutica NVBelgium · 7 shared projects
- Sanofi-Aventis Recherche & DeveloppementFrance · 7 shared projects
- Ucb BiopharmaBelgium · 6 shared projects
- Pfizer LimitedUnited Kingdom · 6 shared projects
- The Chancellor, Masters and Scholars of the University of OxfordUnited Kingdom · 5 shared projects
- Merck Kommanditgesellschaft Auf AktienGermany · 5 shared projects
- F. Hoffmann-La Roche AGSwitzerland · 5 shared projects
- Abbvie IncUnited States · 5 shared projects
- Takeda Pharmaceuticals International AGSwitzerland · 5 shared projects
- Katholieke Universiteit LeuvenBelgium · 4 shared projects
- The University of EdinburghUnited Kingdom · 4 shared projects
- King'S College LondonUnited Kingdom · 4 shared projects
- Astrazeneca ABSweden · 4 shared projects
- Novo Nordisk A/SDenmark · 4 shared projects
- Institut National de la Sante et de la Recherche MedicaleFrance · 3 shared projects
Fields it works in
Research fields recorded on its Horizon projects.
- alzheimer
- biochemistry
- catalysis
- data science
- drug discovery
- entrepreneurship
- epilepsy
- governance
- machine learning
- neurobiology
- obstetrics
- oncology
- parkinson
- pathophysiology
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.
